| 51 |
29018489 | Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis. | 2017 |
2 |
| 52 |
26968895 | Resveratrol inhibits lipogenesis of 3T3-L1 and SGBS cells by inhibition of insulin signaling and mitochondrial mass increase. | 2016 Jun |
2 |
| 53 |
27035655 | CLOCK and BMAL1 Regulate Muscle Insulin Sensitivity via SIRT1 in Male Mice. | 2016 Jun |
1 |
| 54 |
27133915 | The combination of 1α,25dihydroxyvitaminD3 with resveratrol improves neuronal degeneration by regulating endoplasmic reticulum stress, insulin signaling and inhibiting tau hyperphosphorylation in SH-SY5Y cells. | 2016 Jul |
2 |
| 55 |
27456934 | The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials. | 2016 Dec |
1 |
| 56 |
27520400 | Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial. | 2016 Sep |
1 |
| 57 |
27754722 | Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial. | 2016 Nov |
2 |
| 58 |
27852684 | Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. | 2016 Dec |
2 |
| 59 |
25138371 | Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus--systematic review and meta-analysis. | 2015 Jan |
2 |
| 60 |
25139462 | Novel strategies for preventing diabetes and obesity complications with natural polyphenols. | 2015 |
2 |
| 61 |
25445538 | Resveratrol and diabetes: from animal to human studies. | 2015 Jun |
1 |
| 62 |
25451966 | Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. | 2015 Jun |
1 |
| 63 |
25534140 | Thoughts on the progression of type 2 diabetes drug discovery. | 2015 Feb |
1 |
| 64 |
25562512 | Resveratrol mimics insulin activity in the adipogenic commitment of human bone marrow mesenchymal stromal cells. | 2015 Mar |
4 |
| 65 |
25577300 | Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. | 2015 Mar |
2 |
| 66 |
25606815 | Dietary Antioxidants as Modifiers of Physiologic Adaptations to Exercise. | 2015 Sep |
1 |
| 67 |
25612477 | Modulation of SIRT1-Foxo1 signaling axis by resveratrol: implications in skeletal muscle aging and insulin resistance. | 2015 |
2 |
| 68 |
25647160 | Resveratrol prevents oxidative stress-induced senescence and proliferative dysfunction by activating the AMPK-FOXO3 cascade in cultured primary human keratinocytes. | 2015 |
1 |
| 69 |
25897359 | Tyrosine isomers and hormonal signaling: A possible role for the hydroxyl free radical in insulin resistance. | 2015 Apr 15 |
2 |
| 70 |
25941821 | Application of resveratrol in diabetes: rationale, strategies and challenges. | 2015 |
1 |
| 71 |
26305052 | Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol. | 2015 Oct |
2 |
| 72 |
26364558 | Authors' reply to the comment on "Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial" by Shihui Chen et al. [Dig. Liver Dis. 2015;47:226-32]. | 2015 Dec |
1 |
| 73 |
26382727 | Comment on "Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial" by Shihui Chen et al. [Dig. Liver Dis. 2015;47:226-32]. | 2015 Dec |
1 |
| 74 |
24582567 | Resveratrol does not benefit patients with nonalcoholic fatty liver disease. | 2014 Dec |
1 |
| 75 |
24606795 | Mitochondrial biogenesis: pharmacological approaches. | 2014 |
1 |
| 76 |
24695890 | Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials. | 2014 Jun |
5 |
| 77 |
25137036 | Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion. | 2014 Dec |
3 |
| 78 |
25245999 | Resveratrol, inositol, vitamin D and K in the prevention of cardiovascular and osteoporotic risk: a novel approach in peri- and postmenopause. | 2014 Oct |
1 |
| 79 |
29872461 | Resveratrol for the Management of Diabetes and its Downstream Pathologies. | 2014 Feb |
1 |
| 80 |
23315205 | Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells. | 2013 Sep |
1 |
| 81 |
23436883 | Diabetic complications in pregnancy: is resveratrol a solution? | 2013 May |
1 |
| 82 |
23624181 | Resveratrol vs. calorie restriction: data from rodents to humans. | 2013 Oct |
1 |
| 83 |
23884882 | Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet. | 2013 Oct |
1 |
| 84 |
24073011 | Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. | 2013 |
2 |
| 85 |
24199159 | SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential. | 2013 Oct |
1 |
| 86 |
26064836 | High-dose Resveratrol Inhibits Insulin Signaling Pathway in 3T3-L1 Adipocytes. | 2013 Mar |
3 |
| 87 |
22219517 | Pilot study of resveratrol in older adults with impaired glucose tolerance. | 2012 Dec |
2 |
| 88 |
22437738 | Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies. | 2012 Apr |
3 |
| 89 |
22564731 | SIRT1 attenuates palmitate-induced endoplasmic reticulum stress and insulin resistance in HepG2 cells via induction of oxygen-regulated protein 150. | 2012 Jun 1 |
1 |
| 90 |
22898769 | Acute exposure to resveratrol inhibits AMPK activity in human skeletal muscle cells. | 2012 Nov |
3 |
| 91 |
22917016 | Resveratrol upregulates Nrf2 expression to attenuate methylglyoxal-induced insulin resistance in Hep G2 cells. | 2012 Sep 12 |
3 |
| 92 |
21163946 | Resveratrol potentiates glucose-stimulated insulin secretion in INS-1E beta-cells and human islets through a SIRT1-dependent mechanism. | 2011 Feb 25 |
3 |
| 93 |
21241768 | Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. | 2011 Mar 30 |
6 |
| 94 |
21261639 | Anti-diabetic effects of resveratrol. | 2011 Jan |
4 |
| 95 |
21367579 | Polyphenols: planting the seeds of treatment for the metabolic syndrome. | 2011 Jun |
1 |
| 96 |
21385509 | Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. | 2011 Aug |
8 |
| 97 |
21483037 | Resveratrol-activated SIRT1 in liver and pancreatic β-cells: a Janus head looking to the same direction of metabolic homeostasis. | 2011 Apr |
1 |
| 98 |
21689891 | Resveratrol may be beneficial in treatment of diabetic foot syndrome. | 2011 Sep |
1 |
| 99 |
20463039 | Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner. | 2010 Jul |
1 |
| 100 |
20823772 | Resveratrol: a relevant pharmacological approach for the treatment of metabolic syndrome? | 2010 Nov |
1 |